Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.

MLA

Pleguezuelos, Olga, et al. “Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.” Annals of Internal Medicine, vol. 172, no. 7, Apr. 2020, pp. 453–62. EBSCOhost, https://doi.org/10.7326/M19-0735.

APA

Pleguezuelos, O., Dille, J., de Groen, S., Oftung, F., Niesters, H. G. M., Islam, M. A., Næss, L. M., Hungnes, O., Aldarij, N., Idema, D. L., Perez, A. F., James, E., Frijlink, H. W., Stoloff, G., Groeneveld, P., & Hak, E. (2020). Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial. Annals of Internal Medicine, 172(7), 453–462. https://doi.org/10.7326/M19-0735

Chicago

Pleguezuelos, Olga, Joep Dille, Sofie de Groen, Fredrik Oftung, Hubert G.M. Niesters, Md Atiqul Islam, Lisbeth Meyer Næss, et al. 2020. “Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.” Annals of Internal Medicine 172 (7): 453–62. doi:10.7326/M19-0735.